Antimicrobial Wound Gel Market Research Report Information By Product (Silver Dressings, Povidone-iodine Dressings, PHMB Dressings, And Others), By Application (Antimicrobial Wound Dressings for Chronic Wounds And Antimicrobial Wound Dressings for Acute Wounds), By End-use (Antimicrobial Dressings for Hospitals, Antimicrobial Dressings for Outpatient Facilities, Antimicrobial Dressings for Home Care And Antimicrobial Dressings for Research & Manufacturing), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market F

Antimicrobial Wound Gel Market Overview

Antimicrobial Wound Gel Market Size was valued at USD 1.4 Billion in 2023. The Global Antimicrobial Wound Gel Market industry is projected to grow from USD 1.49 Billion in 2024 to USD 2.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.00% during the forecast period (2024 - 2032). The growing geriatric population and an increase in the number of surgical cases and severe wounds are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Antimicrobial Wound Gel Market Trends

• 
  

  Increased Prevalence of Acute and Chronic Injuries And Wound Infections Propels Market Growth

  
  

The rising incidence of chronic wounds is a major factor driving market CAGR in the Antimicrobial Wound Gel Market. Wounds, including acute and chronic wounds, constitute a major healthcare burden worldwide due to their frequency in a variety of acute and chronic disorders. On a global scale, the incidence of both acute and chronic diseases has increased significantly. About 33% of persons worldwide have two or more chronic diseases, generally known as multiple chronic conditions (MCC). Chronic diseases include cardiovascular disease (CVD), cancer, chronic lung disease, and diabetes. MCCs affect around 26% of the population in the United States, 37% in the United Kingdom, and 9.4% in the metropolitan South Asian region.

Chronic wounds consist mostly of DFUs, pressure ulcers, venous ulcers, and surgical site injuries that last more than a month. Chronic wounds cannot heal normally and require specialized wound care therapy. Approximately 1% to 2% of the population in affluent countries is expected to sustain a chronic wound during their lives. Chronic wounds that go untreated might result in amputation or even death. According to the World Health Organisation, the prevalence of nosocomial infections ranges from 3% to 21%, with wound infections accounting for 5% to 34% of the total. All of these events contribute to market expansion.

Moreover, Surgical procedures, both elective and emergency, drive demand for wound care products such as antimicrobial dressings. The growth of surgical interventions, notably in orthopedics and cardiovascular surgery, helps to expand the industry. Patients are frequently left with surgical wounds that require adequate care and treatment to promote healing and prevent infections. Antimicrobial wound care dressings are necessary for this reason because they serve to produce a sterile environment around the wound, lowering the risk of surgical site infections (SSIs). Thus, driving the Antimicrobial Wound Gel Market revenue.

Antimicrobial Wound Gel Market Segment Insights

Antimicrobial Wound Gel Product Insights

The Antimicrobial Wound Gel Market segmentation, based on Product, includes Silver Dressings, Povidone-iodine Dressings, PHMB Dressings, and Others. Silver Wound Dressing is the largest segment, accounting for 39.5% of the market. Silver wound dressings are antimicrobial wound care dressings that use silver as the active element. Silver wound dressings can take many forms, including foam, gauze, hydrocolloid, and alginate dressings. The dressings function by releasing silver ions, which serve to kill or suppress bacteria in the wound bed. Silver wound dressings are very beneficial for treating chronic wounds like pressure ulcers and diabetic foot ulcers, which are prone to infection. They are also used to treat surgical wounds, lowering the risk of infection and promoting speedier recovery.

Figure 1: Antimicrobial Wound Gel Market, by Product, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Antimicrobial Wound Gel Application Insights

The Antimicrobial Wound Gel Market segmentation, based on Application, includes Antimicrobial Wound Dressings for Chronic Wounds And Antimicrobial Wound Dressings for Acute Wounds. The Antimicrobial Wound Dressings for Chronic Wounds segment is expected to lead the market in 2023. Antimicrobial Wound Dressings for Chronic Wounds treat a variety of injuries, including pressure ulcers, lower extremity ulcers, and DFUs. Chronic wounds are a significant public health concern due to their high morbidity and mortality rates. As a result of both direct and indirect costs, they put a significant strain on healthcare systems, which are critical for nations to offer treatment to their citizens.

Antimicrobial Wound Gel End-use Insights

The Antimicrobial Wound Gel Market segmentation, based on Application, includes Antimicrobial Dressings for Hospitals, Antimicrobial Dressings for Outpatient Facilities, Antimicrobial Dressings for Home Care And Antimicrobial Dressings for Research & Manufacturing. In 2023, the market was led by the Antimicrobial Dressings for Hospitals sector. Hospitals are typically the first place where patients with any medical condition seek help. Diabetics who are at risk of developing wounds are usually cared for in hospitals. Moreover, hospitals are equipped with the latest tools and technologies for diagnosing, monitoring wounds, and promoting quick healing. Many hospitals are now restricting visits by providing specialized home care services. Hospital wound care departments frequently manage both infectious and non-infectious conditions in the lower extremities and feet of patients, regardless of whether they have diabetes or not.

Antimicrobial Wound Gel Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. In 2023, North America is projected to lead the antimicrobial wound care gel market, holding a market share of 45.80%. This could be attributed to the existence of key market players, a rise in surgical procedures, and a larger demographic being targeted. For instance, a 2020 NCBI study reported that approximately 40-50 million procedures are performed annually in the United States. Moreover, the rise in hospital-acquired infections is fueling the expansion of the market.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.

Figure 2: Antimicrobial Wound Gel Market Share By Region 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Antimicrobial Wound Gel Market accounts for the second-largest market share. This is due to an increasing senior population, traffic accidents, and incidences of diabetes and burns. India is anticipated to be the world's future diabetic capital. Further, the German Antimicrobial Wound Gel Market held the largest market share, and the UK Antimicrobial Wound Gel Market was the fastest-growing market in the European region.

The Asia-Pacific Antimicrobial Wound Gel Market is expected to grow at the fastest CAGR from 2024 to 2032. The increase can be ascribed to a rising population, medical tourism, and an increase in the incidence of traumatic wounds. Moreover, China’s Antimicrobial Wound Gel Market held the largest market share, and the Indian Antimicrobial Wound Gel Market was the fastest-growing market in the Asia-Pacific region.

Antimicrobial Wound Gel Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Antimicrobial Wound Gel Market grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Antimicrobial Wound Gel industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Antimicrobial Wound Gel industry to benefit clients and increase the market sector. In recent years, the Antimicrobial Wound Gel industry has offered some of the most significant advantages to medicine. Major players in the Antimicrobial Wound Gel Market, including 3M, Smith & Nephew, Cardinal Health, Convatec, Inc., B. Braun SE, Coloplast Corp., McKesson Corporation, Mölnlycke Health Care AB, and others, are attempting to increase market demand by investing in research and development operations.

The 3M Corporation is a worldwide American conglomerate involved in sectors like production, employee protection, medical care, and consumer products. The company manufactures over 60,000 products across different brands, such as adhesives, abrasives, laminates, fire retardants, PPE, window films, paint protection films, dental and orthodontic items, electrical alloys and insulating materials, medical products, car care goods, electronic circuits, health software, and optical films. Maplewood is situated in Saint Paul, Minnesota, a suburb.

Smith and Nephew plc, also known as Smith+Nephew, is a UK-based global healthcare company with its main offices located in Watford, England. It is a worldwide producer of revolutionary wound care devices, arthroscopy products, trauma and clinical care products, and orthopedic reconstructive tools. It is possible to find its products in over 100 countries. It is a member of the FTSE 100 index and is traded on the London Stock Exchange. In March 2019, Smith and Nephew acquired Rotation Medical, Inc. and developed a novel technique for regenerating tissue to repair the rotator cuff in the shoulder.

Key Companies in the Antimicrobial Wound Gel Market include

• 3M


• Smith & Nephew


• Cardinal Health


• Convatec, Inc.


• Braun SE


• Coloplast Corp.


• McKesson Corporation


• Mölnlycke Health Care AB


• Paul Hartmann AG


• Medline Industries

Antimicrobial Wound Gel Industry Developments

In April 2023, Convatec Group Plc declared the purchase of 30 Technology Limited's anti-infective nitric oxide technology platform, which includes new commercial assets and research and development. Convatec aims to broaden the utilization of this innovative technology platform in all its business sectors, not just limited to advanced wound care applications.

In October 2023, Flinders University researchers achieved a significant advancement in wound treatment through the use of innovative technology. By utilizing an atmospheric argon plasma jet, scientists were able to convert Spirulina maxima, a form of blue-green microalgae, into an extremely slim, bioactive film.

Antimicrobial Wound Gel Market Segmentation

Antimicrobial Wound Gel By Product Outlook

• Silver Dressings


• Povidone-iodine Dressings


• PHMB Dressings


• Others

Antimicrobial Wound Gel By Application Outlook

• Antimicrobial Wound Dressings for Chronic Wounds


• Antimicrobial Wound Dressings for Acute Wounds

Antimicrobial Wound Gel By End-use Outlook

• Antimicrobial Dressings for Hospitals


• Antimicrobial Dressings for Outpatient Facilities


• Antimicrobial Dressings for Home Care


• Antimicrobial Dressings for Research & Manufacturing

Antimicrobial Wound Gel Regional Outlook

• 
  
  Middle East
  
  


• 
  
  Africa
  
  


• 
  
  Latin America